Monoclonal antibodies used in immunotherapy are produced artificially from a cell clone therefore consist of a single type of immunoglobulin. They are targeted towards specific antigens and bind to the antigens to form a complex. The complex can be recognized and destroyed by phagocytes or used for other diagnostic purposes. CD30 has been identified as a marker on Reed–Sternberg cells in Hodgkin lymphoma and cells in other specific types of lymphoma. CD30 monoclonal antibodies may be used to treat Hodgkin's lymphoma or anaplastic large cell lymphoma.
By clicking Subscribe, I agree to the Drugs.com Terms & Conditions & Privacy Policy and understand that I may opt out of Drugs.com subscriptions at any time.
